Skip to main content
. 2023 May 26;34(9):1601–1611. doi: 10.1007/s00198-023-06773-z

Table 3.

Estimated means of change in bone mineral density over 6 years by change in body composition groups in body mass stable participants

Group 1
↓LM & ↓FM
Group 2
↓LM & ↑FM
Group 3
↑LM & ↓FM
Group 4
↑LM & ↑FM
P value
Female, n 115 361 167 131
 ∆Total mass (kg) -1.4 ± 0.1 0.2 ± 0.1a -0.4 ± 0.1a,b 1.3 ± 0.1a,b,c <0.001
 ∆Total hip BMD (g/cm2) -0.048 ± 0.004 -0.047 ± 0.002 -0.037 ± 0.003b -0.032 ± 0.004a,b <0.001
 ∆Femoral neck BMD (g/cm2) -0.045 ± 0.004 -0.050 ± 0.002 -0.044 ± 0.003 -0.039 ± 0.004 0.096
 ∆Lumbar spine BMD (g/cm2) -0.035 ± 0.006 -0.039 ± 0.003 -0.033 ± 0.005 -0.031 ± 0.005 0.514
Male, n 147 386 172 110
 ∆Total mass (kg) -1.7 ± 0.1 0.3 ± 0.1a -0.5 ± 0.1a,b 1.7 ± 0.1a,b,c <0.001
 ∆Total hip BMD (g/cm2) -0.012 ± 0.003 -0.016 ± 0.002 -0.006 ± 0.003b -0.008 ± 0.003 0.014
 ∆Femoral neck BMD (g/cm2) -0.021 ± 0.004 -0.021 ± 0.002 -0.007 ± 0.003a,b -0.017 ± 0.004 0.006
 ∆Lumbar spine BMD (g/cm2) 0.033 ± 0.005 0.031 ± 0.003 0.044 ± 0.004 0.028 ± 0.005 0.046

Body mass stable is defined as total body mass change <3% from baseline to follow up. Values are estimated mean ± SEM. BMD, bone mineral density, FM, fat mass, LM, lean mass. aP <0.05 vs Group 1 (↓LM & ↓FM), bP <0.05 vs Group 2 (↓LM & ↑FM), cP <0.05 vs Group 3 (↑LM & ↓FM), general linear model adjusted for race, measurement interval, age, height, smoking history, serum 25-hydroxyvitamin D, physical activity level, sitting hours per day, alcohol consumption, education level and menopausal hormone therapy (in females); models for ∆total mass additionally adjusted for baseline total mass, and models for ∆BMD additionally adjusted for baseline BMD value, lean mass, fat mass, and calcium supplementation